HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Antibac Soap Decline Likely In Reaction To Triclosan Debate

This article was originally published in The Rose Sheet

Executive Summary

FDA’s recent proposal to amend the OTC antiseptic drug product monograph could impact sales of antibacterial soaps, according to analysts from market research firm Kline & Company. Firms will “likely choose the path of least resistance” and replace controversial ingredient triclosan, they predict.


Related Content

Minnesota First State To Ban Triclosan In Personal Cleansing Products
Antibacterial Soaps Reduce Risk Of Foodborne Illness – Industry Study
FDA Says Antiseptics Need Testing Or Face Reformulation, Relabeling

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts